Conservative Treatment of PAS With or Without IIL
PASIIL
Conservative Management of Placenta Accreta Spectrum With or Without Internal Iliac Ligation: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
In the current study, the investigators aimed to compare the benefits of internal iliac ligation in placenta accreta spectrum
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2022
CompletedFirst Posted
Study publicly available on registry
February 10, 2022
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFebruary 28, 2024
February 1, 2024
2.4 years
January 28, 2022
February 26, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Intraoperative blood loss
the volume of blood collected in the suction apparatus, excluding the volume of liquor collected, this will be done by meticulous recording of the blood volume in the suction apparatus before opening the uterus and then calculating the exactly added amount of liquor, so that it becomes excluded from the calculation) to the calculated volume of blood obtained from the pre and postoperative difference in weight of the towels and drapes placed beneath the patients, using the following formula: (WET Item Gram Weight - DRY Item Gram Weight¼milliliters of blood within the item) .
6 months
Cesarean hysterectomy rate
The success of procedure in prevention of hysterectomy
6 months
Secondary Outcomes (2)
Operative time
intraoperative
Operative and postoperative complications
6 months
Study Arms (2)
Study group
EXPERIMENTALConservative management of PAS with Ligation of the bilateral internal iliac arteries
Control group
ACTIVE COMPARATORConservative treatment with Shehata's technique and no internal iliac ligation
Interventions
opening the posterior peritoneum overlying the bifurcation of the common iliac arteries. Then careful dissection of the internal iliac artery is carried out on each side and the anterior division of the internal iliac artery is ligated 4 cm below the bifurcation of the common iliac on both sides by single ligation procedure using Vicryl 1.0 . Re-checking of the femoral pulsation of both sides is performed. Then, the placenta is removed manually in a piecemeal manner, any remaining bleeding points from the placental site are then controlled by hemostatic sutures .
The three-step technique (Shehata's technique) entailed 3 steps, the first step is double bilateral ligation of uterine arteries before placental separation. Uterine artery ligation is made at 2 levels. First will be done at the isthmus and second will be done 1 cm above the cesarean incision. Regarding timing of ligation , we will apply the uterine artery ligation before placental separation to minimize blood loss at the attempt of placental separation. Placenta is separated manually either totally or in piecemeal. If manual separation failed, placenta is removed by scissors. Application of quadruple sutures is done at the lower uterine segment to compress and secure the neovascularization in the bed of placenta. Insertion of triple way catheter is commenced from inside the uterine incision downwards using long artery forceps or uterine sound and the pulled by the assistant from below. The catheter balloon is inflated by 50 cc saline and left for 48 hours
Eligibility Criteria
You may qualify if:
- Age under 35 years old.
- Prenatally diagnosed placenta accreta .
- Planned caesarean section ≤ 37 wks .
- ≤ previous 3 ceserian sections .
- Placenta accretta spectrum grade 1 , 2 ,3 .
- Patients who want to preserve their fertility.
- Patients who refuse hysterectomy .
You may not qualify if:
- Cases with high risk of intraoperative blood loss as hemorrhagic disorders and thrombocytopenia .
- Cases on anticoagulant therapy.
- Patients who completed her family.
- Hemodynamicaly unstable patients.
- Finally cases who refused to get enrolled in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
Study Sites (1)
Ayman Dawood
Tanta, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients only will be masked
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
January 28, 2022
First Posted
February 10, 2022
Study Start
May 1, 2022
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 6 months
- Access Criteria
- full acess
On valuable request